why choose us

First received: October 12, 2022

Clinical Trial: CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Acute Lymphoblastic Leukemia

Study Type: INTERVENTIONAL


Official Title: A Single-Arm, Open-Label Phase 1b Study of Hyper-CVAD + Calaspargase Pegol in Young Adults With Newly Diagnosed Acute Lymphoblastic Leukemia

Brief Summary: The purpose of the study is to evaluate the safety and tolerability of the study drug, calaspargase pegol, when given with multi-agent chemotherapy.

Read more